A new study reports one of the biggest potential advances against heart failure in more than a decade -- a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent.

Sections:  u.s.   
Topics:  New York   Onondaga County   Syracuse   
RELATED ARTICLES
BING NEWS:
  • The Shady Side Of Snapchat
    Snapchat has fallen out of the public eye a little these days, but it's bigger than ever. However, not everything is good in the land of temporary messages.
    04/21/2024 - 11:30 am | View Link
  • Study shows heart failure, not stroke is the most common complication of atrial fibrillation
    The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to one in three over the past two decades, ...
    04/17/2024 - 11:29 am | View Link
  • Verily says its Study Watch could identify heart failure risk
    A study conducted by Verily demonstrated the potential of a wrist-worn device in detecting heart failure risk.
    04/11/2024 - 6:27 am | View Link
  • Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure
    About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
    04/8/2024 - 6:40 am | View Link
  • IBD Stock Of The Day Novo Nordisk: Why A Pullback Is Bullish For The Weight-Loss Kingpin
    The company leads the weight-loss drugs market with its blockbuster, Wegovy. But next-generation drugs are coming.
    04/5/2024 - 5:39 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News